Results of the Women's Self-Performed Anal Pap Trial in Human Immunodeficiency Virus-Infected Women

被引：8

作者：

McNeil, Candice J. ^{[1
]}

Kong, Christina S. ^{[2
]}

Anglemyer, Andrew ^{[3
,4
]}

Levy, Vivian ^{[5
,6
]}

Maldonado, Yvonne ^{[7
]}

机构：

[1] Wake Forest Sch Med, Infect Dis Sect, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA

[2] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA

[3] Calif State Univ, Collaborat Hlth Serv, Monterey, CA USA

[4] Calif State Univ, Human Serv, Monterey, CA USA

[5] San Mateo Cty Hlth Syst, Infect Dis Sect, Stanford, CA USA

[6] Stanford Univ, Div Infect Dis & Geog Med, Stanford, CA 94305 USA

[7] Stanford Univ, Dept Med, Div Pediat Infect Dis, Stanford, CA 94305 USA

来源：

SEXUALLY TRANSMITTED DISEASES | 2016年 / 43卷 / 07期

关键词：

HIV; women; self-performed; anal Pap smear; HPV; HUMAN-PAPILLOMAVIRUS; HPV INFECTION; CANCER; ACCEPTABILITY; PREVALENCE; SOCIETY; RISK; MEN; SEX;

D O I：

10.1097/OLQ.0000000000000448

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

High-risk human papillomavirus anal infections are common in human immunodeficiency virus-infected women. We conducted a crossover study in 30 women seen in a California human immunodeficiency virus clinic, to test the feasibility of self-performed anal Pap smears. Women found the tests acceptable and feasible. Compared with physician-collected specimens, results were highly concordant for anal cytology (kappa = 0.53) and high-risk human papillomavirus typing (kappa = 0.59 inclusive of equivocal results, or kappa = 0.81 excluding equivocal results).

引用

页码：433 / 435

页数：3

共 50 条

[21] INCIDENCE OF VENEREAL WARTS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED AND UNINFECTED WOMEN
CHIRGWIN, KD
FELDMAN, J
AUGENBRAUN, M
LANDESMAN, S
MINKOFF, H
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01): : 235 - 238
[22] Invasive and preinvasive cervical neoplasia in human immunodeficiency virus-infected women
Robinson, W
SEMINARS IN ONCOLOGY, 2000, 27 (04) : 463 - 470
[23] TREATMENT OPTIONS FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PREGNANT-WOMEN
SPERLING, RS
STRATTON, P
OBSTETRICS AND GYNECOLOGY, 1992, 79 (03): : 443 - 448
[24] Prevalence of Chlamydia trachomatis in human immunodeficiency virus-infected women in Cuba
Kouri, V
Cartaya, J
Rodríguez, ME
Muné, M
Soto, Y
Resik, S
Bravo, J
Llop, A
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2002, 97 (08): : 1073 - 1077
[25] Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women
Unadkat, Jashvant D.
Wara, Diane W.
Hughes, Michael D.
Mathias, Anita A.
Holland, Diane T.
Paul, Mary E.
Connor, James
Huang, Sharon
Nguyen, Bach-Yen
Watts, D. Heather
Mofenson, Lynne M.
Smith, Elizabeth
Deutsch, Paul
Kaiser, Kathleen A.
Tuomala, Ruth E.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) : 783 - 786
[26] Longitudinal analysis of bone density in human immunodeficiency virus-infected women
Dolan, Sara E.
Kanter, Jenna R.
Grinspoon, Steven
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (08): : 2938 - 2945
[27] CLUES TO ENHANCING THE IDENTIFICATION OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN - REPLY
STEIN, MD
ROSENE, KA
OBSTETRICS AND GYNECOLOGY, 1993, 81 (01): : 160 - 160
[28] Hysterosalpingographic evaluation of human immunodeficiency virus-infected and uninfected infertile women
Onyangunga, Dolongo C.
Moodley, Jagidesa
SA JOURNAL OF RADIOLOGY, 2020, 24 (01):
[29] PELVIC INFLAMMATORY DISEASE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN - REPLY
KORN, AP
OBSTETRICS AND GYNECOLOGY, 1994, 83 (03): : 482 - 482
[30] Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women
McGowan, JP
Crane, M
Wiznia, AA
Blum, S
OBSTETRICS AND GYNECOLOGY, 1999, 94 (05): : 641 - 646

← 1 2 3 4 5 →